• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Crism Therapeutics Corporation (CRTX)

ORD NPV
Sell: 17.00p|Buy: 18.00p|Change: 0.50 (-2.86%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Company profile

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation anddevelopment.

Address

Kingston Chambers
P.O. Box 173, Tortola
Road Town
VGB

Website

https://www.crismtherapeutics.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Crism Therapeutics Corp Second Quarter Earnings Conference Call for 20262026-09-16T11:00:00
Crism Therapeutics Corp Second Quarter Earnings Results for 20262026-09-15T00:00:00
Crism Therapeutics Corp Annual General Meeting for 20252026-08-26T10:00:00
Crism Therapeutics Corp Fourth Quarter Earnings Results for 20252026-06-12T00:00:00
Crism Therapeutics Corp Annual Report for 20252026-06-12T00:00:00

Previous key dates

NameKey Date
Crism Therapeutics Corp Second Quarter Earnings Conference Call for 20252025-09-16T11:00:00
Crism Therapeutics Corp Second Quarter Earnings Results for 20252025-09-15T00:00:00
Crism Therapeutics Corp Annual General Meeting for 20242025-08-26T10:00:00
Crism Therapeutics Corp Fourth Quarter Earnings Results for 20242025-06-13T00:00:00
Crism Therapeutics Corp Annual Report for 20242025-06-13T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.